http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103099838-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f655e2f89dca077f81462133b71a10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate | 2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68b4157d91ce5a33e655864b2494c86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_554df4c19f17b1b35a5541478ebcb78c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d5814b62399c4084230a16af97626b8 |
| publicationDate | 2013-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103099838-A |
| titleOfInvention | Anti-hepatitis B virus composition taken from fresh dandelion and application of anti-hepatitis B virus composition in preparation of anti-hepatitis B virus drug |
| abstract | The invention relates to an anti-hepatitis B virus composition taken from fresh dandelion and an application of the anti-hepatitis B virus composition in preparation of an anti-hepatitis B virus drug and belongs to the field of traditional Chinese medicines. The anti-hepatitis B virus composition provided by the invention comprises a fresh dandelion polysaccharide component, a phenolic acid component and a flavone component and is characterized in that the weight ratio of the fresh dandelion polysaccharide component to the phenolic acid component to the flavone component is (2-40): (3-70): (2-50). According to an optimized scheme, the phenolic acid component takes caffeic acid, chlorogenic acid and isochlorogenic acid A as typical ingredients; the flavone component takes galuteolin, quercetin and luteolin as typical ingredients; and the weight ratio of the caffeic acid to the chlorogenic acid to the isochlorogenic acid A to the galuteolin to the quercetin to the luteolin is (0.25-10): (2-40): (0.25-20): (0.5-20): (0-10): (1.5-20). According to the invention, the fresh dandelion is taken as raw material, effective ingredients are separated, purified and enriched by macroporous resin, the effective ingredients are mixed to obtain the fresh dandelion anti-hepatitis B virus composition, a process is simple and convenient, related diseases caused by hepatitis B viruses can be effectively treated, cost is low, and mass production can be achieved. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107998166-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7008368-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11235015-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109364254-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105213453-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113577123-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113425757-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109364254-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113040300-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108992436-A |
| priorityDate | 2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.